Sangeeta Paul

Sangeeta Paul

BSc Pharmacy, MSc Pharmacy, Ph.D. Pharmacology

Sangeeta Paul is a researcher and medical writer based in Gurugram, India. Her academic background is in Pharmacy; she has a Bachelor’s in Pharmacy, a Master’s in Pharmacy (Pharmacology), and Ph.D. in Pharmacology from Banasthali Vidyapith, Rajasthan, India. She also holds a post-graduate diploma in Drug regulatory affairs from Jamia Hamdard, New Delhi, and a post-graduate diploma in Intellectual Property Rights, IGNOU, India.

See more

She has extensive experience in pre-clinical research as a part of her research projects undertaken at the Central Drug Research Institute (CDRI), Lucknow, India. Her research works involved the assessment of phytoconstituents derived from berry-bearing plants on learning and memory-enhancing activity using in vivo and in vitro models.

Sangeeta has co-authored research papers published in reputed journals like Springer Nature and has also served as a reviewer for peer-reviewing manuscripts of reputed journals. She is also a certified Publon Peer Reviewer.

Sangeeta has presented many posters and oral presentations in scientific conferences and attended many scientific workshops. She has worked as a lecturer and research analyst and is passionate about health, secondary research, and medical writing. When she is not working, she enjoys traveling and cooking.

See less

Articles from Sangeeta

Study rules out post-COVID-19 conditions in hospitalized patients in South Africa

Study rules out post-COVID-19 conditions in hospitalized patients in South Africa

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

SARS-CoV-2 spike protein characteristics responsible for viral evolution in human hosts

SARS-CoV-2 spike protein characteristics responsible for viral evolution in human hosts

Researchers develop scoring tools to determine hospitalization and mortality risk in COVID-19 patients

Researchers develop scoring tools to determine hospitalization and mortality risk in COVID-19 patients

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

Severity of COVID-19 cases in the months of Alpha variant predominance compared to the Delta variant

Severity of COVID-19 cases in the months of Alpha variant predominance compared to the Delta variant

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Study explores signature gut microbiome connection with immune checkpoint inhibitor response in advanced melanomas

Study explores signature gut microbiome connection with immune checkpoint inhibitor response in advanced melanomas